G. Shaw

S. J. Clark, G. Shaw, H. Farzadegan, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection

G. Learn, B. Haynes, I. Williams, 2019, Proceedings of the National Academy of Sciences.

Molecular biology of human T-lymphotropic retroviruses.

G. Shaw, B. Hahn, L. Ratner, 1985, Cancer research.

HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies

B. Haynes, D. Montefiori, S. Meshnick, 2011, Journal of Virology.

Transmitted/Founder Hepatitis C Viruses Induce Cell-Type- and Genotype-Specific Differences in Innate Signaling within the Liver

G. Shaw, Hui Li, S. Khetani, 2015, mBio.

Transfusion transmission of retroviruses: human T‐lymphotropic virus types I and II compared with human immunodeficiency virus type 1

E. Schiff, G. Shaw, S. Kleinman, 1994, Transfusion.

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

Phuc T. Pham, Jerome H. Kim, B. Korber, 2017, PLoS pathogens.

Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth

Bette Korber, Gwo-Yu Chuang, Peter D. Kwong, 2018, Cell reports.

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth

Chaim A. Schramm, T. Kepler, B. Korber, 2020, Science.

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth

Chaim A. Schramm, T. Kepler, B. Korber, 2020, Science.

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

A. Lapedes, G. Learn, B. Korber, 2015, Viruses.

Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection

Ethan Romero-Severson, Bette Korber, Hui Li, 2018, Nature Communications.

Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis.

T. R. Broker, G. Shaw, B. V. Van Tine, 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Virus-Specific CD 8 + Cytotoxic T-Lymphocyte Activity Associated with Control of Viremia in Primary Human Immunodeficiency Virus Type 1 Infection

Lewicki, G. Shaw, B. Hahn, 2022 .

A meta-analysis of passive immunization studies shows an association of serum neutralizing antibody titer with protection against SHIV challenge

Lindsay N. Carpp, J. Mascola, D. Burton, 2019 .

Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages

B. Korber, W. Fischer, N. Letvin, 2012, Journal of Virology.

Distinct Evolutionary Pressures Underlie Diversity in Simian and

W. Fischer, N. Letvin, G. Shaw, 2012 .

Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques

G. Shaw, R. Veazey, Hui Li, 2021, Journal of Virology.

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes

Taina T. Immonen, J. Mascola, P. Bieniasz, 2019, PLoS pathogens.

Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1

A. Lapedes, B. Korber, Haiyan Chen, 2013, Journal of Virology.

Strategy for Immunogen Design CCR 5 Utilization and Suggests a New Identifies Differences in Glycosylation and C Human Immunodeficiency Virus Type 1 Acute and Chronic Infections with Subtype Comparison of Viral Env Proteins from

Cassandra, E. L. Potter, Vermeulen, 2013 .

Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.

G. Shaw, S. Lemon, V. Shah, 2015, Gastroenterology.

Clustered IgG on human red blood cell membranes may promote human lymphocyte antibody-dependent cell-mediated cytotoxicity.

G. Shaw, S. Balcerzak, A. Lobuglio, 1980, Journal of immunology.

Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification

A. Perelson, G. Learn, Tanmoy Bhattacharya, 2015, Journal of Virology.

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

Feng Gao, Lynn Morris, John R. Mascola, 2011, Journal of Virology.

Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C

G. Shaw, Hui Li, D. Barouch, 2020, Journal of Virology.

An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I)

David L. Robertson, Martine Peeters, George M. Shaw, 1998, Journal of Virology.

Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length

G. Shaw, Hui Li, M. Gale, 2015, Journal of Virology.

Recognition of Hepatitis C Virus Transmitted / founder 1 Variants by RIGI is dependent on U-Core length 2 3 4

G. Shaw, Hui Li, M. Gale, 2015 .

Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

L. Hood, G. Shaw, B. Hahn, 1988, Science.

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

F. Alt, B. Haynes, A. McMichael, 2022, Nature reviews. Immunology.

HIV-1 sequence subtype D in the United States.

P. Sharp, D. Robertson, G. Shaw, 1994, AIDS research and human retroviruses.

Edinburgh Research Explorer A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1

P. Sharp, D. Robertson, G. Shaw, 1998 .

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

G. Shaw, B. Hahn, M. Saag, 1991, The Journal of infectious diseases.

The Mutation Rate Estimates Are Robust to Different Choice of Parameters

A. Perelson, G. Learn, B. Korber, 2022 .

394 – Biology of Human Immunodeficiency Viruses

G. Shaw, 2012 .

Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.

G. Learn, J. Kappes, B. Haynes, 2013, Virology.

Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I

G. Shaw, B. Hahn, L. Ratner, 1985, Journal of virology.

The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures

J. Kappes, G. Shaw, B. Hahn, 1995, Journal of virology.

gp120-mediated alterations in astrocyte ion transport.

D. Benos, G. Shaw, B. Hahn, 1994, Advances in neuroimmunology.

Edinburgh Research Explorer Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees sequences

Z. Weng, P. Sharp, G. Shaw, 2018 .

Generation of Infectious Molecular Clones of Simian Immunodeﬁciency Virus from Fecal Consensus Sequences of Wild Chimpanzees (cid:1)

Z. Weng, P. Sharp, G. Shaw, 2007 .

Dissecting the Neutralizing Antibody Speciﬁcities of Broadly Neutralizing Sera from Human Immunodeﬁciency Virus Type 1-Infected Donors (cid:1)

D. Richman, R. Doms, D. Burton, 2007 .

Predictors of Nonseroconversion after SARS-CoV-2 Infection

John P. Moore, P. Bieniasz, T. Ketas, 2021, Emerging infectious diseases.

Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates

John P. Moore, D. Burton, D. Montefiori, 2021, PLoS pathogens.

Response : HIV and AIDS

Michael A. Piatak, J. Lifson, G. Shaw, 1993, Science.

Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1

M. Hudgens, B. Haynes, G. Shaw, 2022, NPJ vaccines.

Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model

Alan D. Curtis, G. Shaw, K. Bar, 2019, mBio.

Analytical treatment interruption after short-term anti-retroviral therapy in a postnatally SHIV infected infant rhesus macaque model

Alan D. Curtis, G. Shaw, K. Bar, 2019, bioRxiv.

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

J. Kappes, G. Shaw, B. Hahn, 1995, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques.

G. Shaw, R. Veazey, Hui Li, 2021, Journal of virology.

Analysis of Neutralization Speciﬁcities in Polyclonal Sera Derived from Human Immunodeﬁciency Virus Type 1-Infected Individuals (cid:1)

J. Mascola, R. Wyatt, S. Migueles, 2008 .

Human lymphocyte, monocyte, and neutrophil antibody-dependent cell-mediated cytotoxicity toward human erythrocytes.

G. Shaw, A. Lobuglio, P. C. Levy, 1978, Cellular immunology.

Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX.

M. Gonda, G. Shaw, B. Hahn, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users

G. Learn, B. Haynes, G. Shaw, 2014, Open forum infectious diseases.

Determination of plasma viral load in HIV‐1 infection by quantitative competitive polymerase chain reaction

S. J. Clark, J. Kappes, J. Lifson, 1993, AIDS.

Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss.

G. Shaw, M. Saag, J. Kilby, 1997, AIDS research and human retroviruses.

Human lymphocyte antibody-dependent cell-mediated cytotoxicity (ADCC) toward human red blood cells.

G. Shaw, A. Lobuglio, P. C. Levy, 1978, Blood.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

J. L. Harmon, B. Haynes, W. Wilkinson, 2000, AIDS research and human retroviruses.

SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques

J. Lifson, G. Shaw, N. Schoof, 2020, Journal of Virology.

High multiplicity infection following transplantation of hepatitis C virus-positive organs.

G. Learn, G. Shaw, Shuyi Wang, 2019, The Journal of clinical investigation.

West African HIV-2-related human retrovirus with attenuated cytopathicity.

J. Kappes, J. Hoxie, G. Shaw, 1988, Science.

Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection

Laura L. Sutherland, B. Haynes, D. Montefiori, 2022, Science Translational Medicine.

Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection.

M. Daucher, A. Fauci, G. Pantaleo, 1996, Proceedings of the National Academy of Sciences of the United States of America.

HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC

Bette Korber, Guido Ferrari, Tanmoy Bhattacharya, 2009, PLoS pathogens.

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome

Hui Li, Guido Ferrari, Tanmoy Bhattacharya, 2012, Retrovirology.

Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing

Alan S. Perelson, Hui Li, Tanmoy Bhattacharya, 2012, PLoS pathogens.

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

G. Shaw, S. Ray, Shuyi Wang, 2022, The Journal of clinical investigation.

HCV Infection Induces Autocrine Interferon Signaling by Human Liver Endothelial Cell and Release of Exosomes, Which Inhibits Viral Replication

G. Shaw, V. Shah, Hui Li, 2016 .

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

Feng Gao, Bette Korber, Tongye Shen, 2011, PLoS pathogens.

Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV

Persephone Borrow, Anthony S. Fauci, Michael S. Saag, 1994, Nature.

Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity.

G. Shaw, A. Lobuglio, P. C. Levy, 1978, Journal of immunology.

Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis.

G. Shaw, A. Lobuglio, P. C. Levy, 1979, Journal of immunology.

Simian Immunodeficiency Virus Infection in Free-Ranging Sooty Mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: Implications for the Origin of Epidemic Human Immunodeficiency Virus Type 2

John F. Y. Brookfield, Friederike Range, Martine Peeters, 2005, Journal of Virology.

Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome.

M. Rosenblum, A. Haase, G. Shaw, 1992, Human pathology.

Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.

G. Shaw, A. Lobuglio, P. C. Levy, 1978, The Journal of clinical investigation.

Human Monocyte Antibody-Dependent Cell-Mediated

G. Shaw, A. Lobuglio, P. C. Levy, 1978 .

Biological parameters of HIV‐1 infection in primary intestinal lymphocytes and macrophages

G. Shaw, G. Meng, Phillip D. Smith, 2000, Journal of leukocyte biology.

Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa.

G. Shaw, P. D. Smith, G. Meng, 2000, The Journal of infectious diseases.

A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies

B. Haynes, D. Burton, D. Montefiori, 2022, bioRxiv.

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome

A. Perelson, B. Haynes, Tanmoy Bhattacharya, 2012, Retrovirology.

Phenotypic properties of transmitted founder HIV-1

Feng Gao, Bette Korber, Hui Li, 2013, Proceedings of the National Academy of Sciences.

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

G. Learn, J. Kappes, P. Sharp, 2009, Cell host & microbe.

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing

A. Branch, G. Shaw, Hui Li, 2020, PloS one.

HIV-1 Vpu Mediates HLA-C Downregulation.

M. Carrington, B. Walker, R. Apps, 2016, Cell host & microbe.

Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes

J. Kappes, G. Shaw, B. Hahn, 1991, Journal of virology.

Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients.

G. Shaw, J. Garcia, L. Ratner, 1991, Virology.

HTLV-III infection in brains of children and adults with AIDS encephalopathy.

G. Shaw, B. Hahn, B. Navia, 1985, Science.

Etiology of AIDS: biological and biochemical characteristics of HTLV-III.

G. Shaw, B. Hahn, R. Gallo, 1985, Advances in experimental medicine and biology.

Molecular cloning and analysis of a new variant of human T‐cell leukemia virus (HTLV‐Ib) from an African patient with adult T‐cell leukemia‐lymphoma

Mikulas Popovic, G. Shaw, B. Hahn, 1984, International journal of cancer.

Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.

G. Shaw, B. Hahn, S. Arya, 1984, Science.

Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI

G. Shaw, B. Hahn, L. Ratner, 2022 .

Bis-Anthracycline Antibiotics Inhibit Human Immunodeficiency Virus Type 1 Transcription

G. Shaw, D. N. Levy, O. Kutsch, 2004, Antimicrobial Agents and Chemotherapy.

Amphotericin-B-mediated reactivation of latent HIV-1 infection.

G. Shaw, O. Kutsch, E. Benveniste, 2005, Virology.

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

J. Kappes, G. Shaw, J. Orenstein, 2002, Nature Medicine.

Inhibition of Protein Degradation in Mouse Hearts by Agents That Cause Lysosomal Dysfunction

R. Nerem, G. Shaw, S. Rittgers, 2005 .

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

Mark Connors, John R Mascola, J. Mascola, 2007, Nature Medicine.

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

S. J. Clark, J. Kappes, G. Shaw, 1991, The New England journal of medicine.

Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions

G. Shaw, B. Hahn, R. Gallo, 1987, Journal of virology.

Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.

G. Shaw, B. Hahn, J. Groopman, 1984, Science.

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

M. Daucher, A. Fauci, L. Perrin, 1997, Proceedings of the National Academy of Sciences of the United States of America.

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

S. J. Clark, J. Kappes, J. Lifson, 1993, Science.

HIV viral load markers in clinical practice

D. R. Kuritzkes, D. Richman, P. Volberding, 1996, Nature Medicine.

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

R. Redfield, M. Taylor, G. Shaw, 1986, Science.

Origin of the human malaria parasite Plasmodium falciparum in gorillas

J. Rayner, G. Learn, P. Sharp, 2010, Nature.

Eastern Chimpanzees, but Not Bonobos, Represent a Simian Immunodeficiency Virus Reservoir

G. Learn, V. Reynolds, P. Sharp, 2012, Journal of Virology.

Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz

J. Jones, G. Learn, P. Sharp, 2009, Nature.

Human immunodeficiency viruses: SIV infection in wild gorillas

P. Sharp, G. Shaw, B. Hahn, 2006, Nature.

Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat

G. Shaw, B. Hahn, M. Peeters, 2002, Emerging infectious diseases.

Molecular cloning and characterization of the HTLV-III virus associated with AIDS

G. Shaw, B. Hahn, S. Arya, 1984, Nature.

Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.

W. Blattner, G. Shaw, G. Reyes, 1992, The Journal of infectious diseases.

Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120

J. Kappes, G. Shaw, W. O'brien, 2000, Journal of Virology.

A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase

Michael S. Saag, George M. Shaw, J. Kappes, 1993 .

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

M. Gonda, J. Hoxie, G. Shaw, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee

G. Learn, P. Sharp, J. Lifson, 2017, Retrovirology.

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers

J. Mellors, G. Shaw, R. Ribeiro, 2016, PLoS pathogens.

Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection

G. Gottlieb, N. Kiviat, G. Shaw, 2011, Journal of Virology.

Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing

G. Learn, D. Montefiori, S. Meshnick, 2010, Journal of Virology.

Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission

Bette T. Korber, Cynthia A. Derdeyn, Eric Hunter, 2004, Science.

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology

H Hui, D. Ho, F. Gao, 1994, Journal of virology.

Assignment1 of human MFNG, manic fringe Drosophila homolog, to 22q13.1 using tyramide fluorescence in situ hybridization (T-FISH)

G. Shaw, W. May, B. V. Van Tine, 1999, Cytogenetic and Genome Research.

Multigenomic Delineation of Plasmodium Species of the Laverania Subgenus Infecting Wild-Living Chimpanzees and Gorillas

Sesh A. Sundararaman, J. Rayner, G. Learn, 2016, Genome biology and evolution.

Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique.

A. Butler, P. Deloukas, G. Shaw, 1998, Genomics.

Simian Immunodeficiency Virus Infection of Chimpanzees

George M. Shaw, P. Sharp, G. Shaw, 2005, Journal of Virology.

Human infection by genetically diverse SIVSM-related HIV-2 in West Africa

F. Gao, P. Sharp, G. Shaw, 1992, Nature.

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

A. Bartesaghi, M. Borgnia, B. Haynes, 2021, Cell.

Biologically diverse molecular variants within a single HIV-1 isolate

David Looney, Michael S. Saag, Amanda G. Fisher, 1988, Nature.

Extensive variation of human immunodeficiency virus type-1 in vivo

G. Shaw, B. Hahn, M. Saag, 1988, Nature.

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

R. Redfield, G. Shaw, B. Hahn, 1985, Science.

Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection

G. Shaw, E. Murphy, S. Wiktor, 1990, The Lancet.

Viral dynamics in primary HIV-1 infection

S. J. Clark, J. Kappes, G. Shaw, 1993, The Lancet.

Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages

H. Ding, J. Kappes, B. Haynes, 2011, Journal of Virology.

African origin of the malaria parasite Plasmodium vivax

Sesh A. Sundararaman, J. Rayner, G. Learn, 2014, Nature Communications.

Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria

Sesh A. Sundararaman, F. Bushman, J. Rayner, 2013, Proceedings of the National Academy of Sciences.

Functional Analysis of the Simian Immunodeficiency Virus Vpx Protein: Identification of Packaging Determinants and a Novel Nuclear Targeting Domain

G. Shaw, B. Hahn, M. Santiago, 2001, Journal of Virology.

Complementation of integrase function in HIV‐1 virions

J. Boeke, M. Soares, G. Shaw, 1997, The EMBO journal.

Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo

G. Shaw, P. Westervelt, B. Hahn, 1992, Journal of virology.

Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate

J. Kappes, J. Hoxie, G. Shaw, 1990, Journal of virology.

CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses

P. Sharp, G. Shaw, B. Hahn, 2021, Proceedings of the National Academy of Sciences.

CD4 receptor diversity in chimpanzees protects against SIV infection

C. Boesch, G. Learn, P. Sharp, 2019, Proceedings of the National Academy of Sciences.

Macrophage HIV‐1 infection and the gastrointestinal tract reservoir

G. Shaw, J. Salazar-Gonzalez, G. Meng, 2003, Journal of leukocyte biology.

High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds.

J. Hartman, G. Shaw, O. Kutsch, 2007, Assay and drug development technologies.

Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency

G. Shaw, D. N. Levy, O. Kutsch, 2002, Journal of Virology.

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice.

N. Letvin, G. Shaw, B. Hahn, 2003, AIDS research and human retroviruses.

New Simian Immunodeficiency Virus Infecting De Brazza's Monkeys (Cercopithecus neglectus): Evidence for a Cercopithecus Monkey Virus Clade

P. Sharp, G. Shaw, B. Hahn, 2004, Journal of Virology.

CD154-CD40-induced reactivation of latent HIV-1 infection.

G. Shaw, D. N. Levy, O. Kutsch, 2003, Virology.

Mucosal Simian Immunodeficiency Virus Transmission in African Green Monkeys: Susceptibility to Infection Is Proportional to Target Cell Availability at Mucosal Sites

G. Shaw, N. Parrish, B. Hahn, 2012, Journal of Virology.

Mother-to-infant transmission of the human immunodeficiency virus during primary infection.

G. Shaw, G. Aldrovandi, B. V. Van Tine, 1999, The New England journal of medicine.

HIV transmission.

G. Shaw, E. Hunter, G. M. Shaw, 2012, Cold Spring Harbor perspectives in medicine.

Quantification of platelet-bound IgG by 125I-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders.

G. Shaw, A. Lobuglio, J. Axelson, 1984, Blood.

Immune thrombocytopenic purpura. Use of a 125I-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG.

G. Shaw, A. Lobuglio, W. Court, 1983, The New England journal of medicine.

Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology

N. Haigwood, G. Shaw, K. Bar, 2019, Journal of Virology.

Infection of gastrointestinal tract macrophages by HIV‐1

G. Shaw, G. Meng, Phillip D. Smith, 1997, Journal of leukocyte biology.

Origin and Biology of Simian Immunodeficiency Virus in Wild-Living Western Gorillas

G. Learn, P. Sharp, G. Shaw, 2008, Journal of Virology.

Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.

P. Sharp, G. Shaw, B. Hahn, 1994, The EMBO journal.

Species-specific diversity among simian immunodeficiency viruses from African green monkeys

M. Taylor, G. Shaw, B. Hahn, 1991, Journal of virology.

Adaptation of HIV-1 to its human host.

Louise V Wain, Martine Peeters, L. Wain, 2007, Molecular biology and evolution.

Relative resistance of HIV-1 founder viruses to control by interferon-alpha

H. Ding, J. Kappes, I. Williams, 2013, Retrovirology.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Feng Gao, Hui Li, Guido Ferrari, 2012, The Journal of clinical investigation.

Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection

Alan S. Perelson, Guido Ferrari, Vitaly V. Ganusov, 2011, Journal of Virology.

Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients

Jessica L. Prince, A. Perelson, G. Shaw, 2015, PLoS pathogens.

Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

Xiping Wei, Persephone Borrow, George M. Shaw, 1997, Nature Medicine.

Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1

Xiping Wei, Cynthia A. Derdeyn, Eric Hunter, 2006, Journal of Virology.

Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA

Martin A. Nowak, Cynthia A. Derdeyn, Michael S. Saag, 1999, The Journal of experimental medicine.

Cytotoxic T‐lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

G. Shaw, P. Borrow, 1998, Immunological reviews.

Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations.

M A Nowak, R M May, S Bonhoeffer, 1997, Journal of theoretical biology.

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

Chaim A. Schramm, Cinque S. Soto, T. Kepler, 2016, Cell.

Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex.

D. Benos, G. Shaw, B. Hahn, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

G. Shaw, P. Borrow, B. Hahn, 1994, Journal of virology.

Individuals infected with HIV possess antibodies against IL-2.

G. Shaw, B. Hahn, M. Saag, 1988, Immunology.

Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents.

D. Robertson, G. Shaw, B. Hahn, 2001, AIDS research and human retroviruses.

SIVcpz in wild chimpanzees.

C. Boesch, P. Sharp, G. Shaw, 2002, Science.

Autologous Neutralizing Antibodies to the Transmitted/Founder Viruses Emerge Late after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys

B. Korber, P. Hraber, N. Letvin, 2010, Journal of Virology.

Molecular Ecology and Natural History of Simian Foamy Virus Infection in Wild-Living Chimpanzees

N. Gross-Camp, C. Boesch, P. Sharp, 2008, PLoS pathogens.

Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).

W. Blattner, J. Lautenberger, M. Reitz, 1994, AIDS research and human retroviruses.

Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins.

D. Burton, D. Montefiori, P. Bieniasz, 2014, Cell host & microbe.

Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5

R. Doms, John P. Moore, R. Berro, 2012, Journal of Virology.

A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity

A. Perelson, B. Korber, B. Haynes, 2011, PloS one.

Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins

J. Sodroski, B. Haynes, R. Doms, 2011, Journal of Virology.

A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251

G. Shaw, B. Hahn, B. Keele, 2010, Journal of Virology.

Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1

Cynthia A. Derdeyn, Eric Hunter, Brandon F. Keele, 2009, PLoS pathogens.

Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques

M. Betts, G. Shaw, Hui Li, 2016, PLoS pathogens.

Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas

G. Learn, D. Ho, J. Mascola, 2015, mBio.

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

R. Swanstrom, H. Chu, B. Korber, 2009, Journal of Virology.

Molecular Identification of Transmitted/Founder Hepatitis C Viruses and Their Progeny by Single Genome Sequencing.

G. Shaw, Hui Li, Shuyi Wang, 2018, Methods in molecular biology.

Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.

J. Sodroski, B. Haynes, D. Burton, 2015, Virology.

Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design

E. L. Potter, Cassandra B. Jabara, H. Chu, 2013, Journal of Virology.

Heterogeneity in Neutralization Sensitivities of Viruses Comprising the Simian Immunodeficiency Virus SIVsmE660 Isolate and Vaccine Challenge Stock

G. Learn, G. Shaw, B. Hahn, 2013, Journal of Virology.

A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.

G. Shaw, N. Parrish, L. Ping, 2010, Virology.

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1

Alan S. Perelson, Hui Li, Gary J. Nabel, 2009, The Journal of experimental medicine.

Simian Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon

P. Sharp, G. Shaw, B. Hahn, 2005, Journal of Virology.

Estimating the Timing of Early Simian-Human Immunodeficiency Virus Infections: a Comparison between Poisson Fitter and BEAST

B. Korber, Tanmoy Bhattacharya, G. Shaw, 2020, mBio.

Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

G. Learn, H. Liao, J. Sodroski, 2016, Proceedings of the National Academy of Sciences.

Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing.

G. Learn, M. John, S. Mallal, 2013, The Journal of infectious diseases.

Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

H. Ding, J. Kappes, B. Haynes, 2012, PLoS pathogens.

Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape

Alan S. Perelson, Feng Gao, Hui Li, 2012, PLoS pathogens.

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

B. Haynes, R. Doms, F. Gao, 2011, Journal of Virology.

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men

Alan S. Perelson, Hui Li, Tanmoy Bhattacharya, 2010, PLoS pathogens.

Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users

Hui Li, Chuanxi Sun, Truman Grayson, 2010, Journal of Virology.

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

H. Chu, B. Korber, B. Haynes, 2009, Journal of Virology.

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.

D. Montefiori, G. Shaw, B. Hahn, 2009, Virology.

Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma

J. Hoxie, G. Shaw, B. Hahn, 2008, Journal of Virology.

Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design

B. Haynes, S. Self, G. Shaw, 2008, Journal of Virology.

Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing

Alan S. Perelson, Timothy C. Wallstrom, Tanmoy Bhattacharya, 2010, PloS one.

Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants

G. Learn, B. Haynes, D. Montefiori, 2013, Retrovirology.

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4

Hui Li, Charles M. Rice, Wenge Ding, 2015, mBio.

Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation

P. Sharp, G. Shaw, B. Hahn, 1992, Journal of virology.

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

R. Siliciano, P. Sharp, M. Nussenzweig, 2021, Science Translational Medicine.

Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption

R. Siliciano, P. Sharp, M. Nussenzweig, 2020 .

HIV-Host Interactions: Implications for Vaccine Design.

B. Korber, J. Sodroski, B. Haynes, 2016, Cell host & microbe.

Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection

I. Williams, G. Shaw, P. Borrow, 2011, Retrovirology.

Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1

M. Hudgens, B. Haynes, G. Shaw, 2022, npj Vaccines.

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness

G. Learn, B. Haynes, P. Sharp, 2017, Proceedings of the National Academy of Sciences.

Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection

G. Learn, J. Lifson, G. Shaw, 2016, Journal of Virology.

Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site

Richard T. Wyatt, John R. Mascola, Mark Connors, 2012, Journal of Virology.

Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy

Guido Ferrari, Hui Li, David Margolis, 2011, PloS one.

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies

Ming Li, Feng Gao, Amit Kumar, 2010, PLoS Comput. Biol..

Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys

B. Haynes, K. Mansfield, N. Letvin, 2010, Journal of Virology.

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

D. Watkins, J. Lifson, G. Shaw, 2009, Journal of Virology.

Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

Lynn Morris, Michael S. Seaman, John R. Mascola, 2008, Journal of Virology.

Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI

W. Greene, G. Shaw, F. Kirchhoff, 2010, Retrovirology.

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.

B. Korber, P. Hraber, H. Liao, 2015, Cell host & microbe.

Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region

Lynn Morris, John R. Mascola, Salim S. Abdool Karim, 2009, Journal of Virology.

Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors

Lynn Morris, Peter B. Gilbert, John R. Mascola, 2009, Journal of Virology.

Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals

John R. Mascola, Mark K. Louder, Mark Connors, 2008, Journal of Virology.

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline

Michael S Saag, Edward P Acosta, Anju Bansal, 2008, AIDS.

Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection

S. Munir Alam, Susan Zolla-Pazner, Barton F. Haynes, 2007, Journal of Virology.

Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection

Hui Li, G. Shaw, S. Karim, 2007, Journal of Virology.

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Douglas D. Richman, Welkin E. Johnson, Dennis R. Burton, 2007, Journal of Virology.

Human Immunodeﬁciency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection (cid:1)

H. Liao, Laura L. Sutherland, B. Haynes, 2007 .

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from 1 HIV-1 infected donors 2 *

R. Doms, D. Burton, G. Shaw, 2007 .

Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5.

G. Shaw, P. D. Smith, G. Meng, 1999, Gastroenterology.

Widely varying SIV prevalence rates in naturally infected primate species from Cameroon.

G. Shaw, B. Hahn, M. Peeters, 2006, Virology.

Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections

G. Shaw, S. Joag, O. Narayan, 1998, Journal of Virology.

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

J. Sodroski, B. Haynes, D. Kaufmann, 2017, Journal of Virology.

Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes

Alan D. Curtis, M. Hudgens, G. Shaw, 2019, Journal of Virology.

Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity

J. Sodroski, D. Kaufmann, G. Shaw, 2015, EBioMedicine.

Small CD 4 Mimetics Prevent HIV-1 Uninfected Bystander CD 4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity

J. Sodroski, D. Kaufmann, G. Shaw, 2016 .

An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum

J. Kappes, B. Haynes, J. Hoxie, 2011, Journal of Virology.

Conformational Epitope Mediates Potent ADCC Activity and Defines a Common 2

J. Kappes, B. Haynes, J. Hoxie, 2011 .

Re-examination of the EA rosette assay (Ripley) for Fc receptor leucocytes.

G. Shaw, A. Lobuglio, P. C. Levy, 1979, Clinical and experimental immunology.

Quantitative Assessment of HIV Replication and Variation In Vivo: Relevance to Disease Pathogenesis and Response to Therapy.

G. Shaw, 1994 .

Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.

G. Learn, G. Shaw, S. Ray, 2017, JCI insight.

Neutralizing IgG at the Portal of Infection Mediates Protection against Vaginal Simian/Human Immunodeficiency Virus Challenge

P. Hraber, H. Liao, B. Haynes, 2013, Journal of Virology.

Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.

A. Fauci, G. Pantaleo, G. Shaw, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]

Alan S. Perelson, Tanmoy Bhattacharya, Eric Delwart, 2012 .

Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART

Jennifer S. Wood, G. Shaw, K. Bar, 2021, JCI insight.

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability

J. Mascola, R. Wyatt, C. Bewley, 2016, PLoS pathogens.

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability

J. Mascola, R. Wyatt, C. Bewley, 2016, PLoS pathogens.

Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients.

S. J. Clark, T. Quinn, G. Shaw, 1994, The Journal of infectious diseases.

The etiology of AIDS.

G. Shaw, R. Gallo, Markham Pd, 1985 .

Wild bonobos host geographically restricted malaria parasites including a putative new Laverania species

Sesh A. Sundararaman, G. Learn, P. Sharp, 2017, Nature Communications.

Genetic variants of human T-lymphotrophic virus type II in American Indian groups.

P. Sharp, M. Taylor, G. Shaw, 1996, Virology.

Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.

Feng Gao, Zhiping Weng, Z. Weng, 2007, Virology.

Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells

R. Siliciano, G. Shaw, N. Schoof, 2020, Journal of virology.

The acute retroviral syndrome and the pathogenesis of HIV-1 infection.

S. J. Clark, G. Shaw, George M. Shaw, 1993, Seminars in immunology.

Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.

J. Kappes, G. Shaw, B. Hahn, 1993, Virology.

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin

H Hui, F. Gao, P. Sharp, 1996, Journal of virology.

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

F. Alt, B. Haynes, A. McMichael, 2022, Nature Reviews Immunology.

Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC

L. Hood, J. Kappes, G. Shaw, 1988, Journal of virology.

Human immunodeficiency virus type 2 vpx protein augments viral infectivity.

J. Kappes, G. Shaw, B. Hahn, 1991, Virology.

New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure

B. Haynes, J. Lifson, G. Shaw, 2021, bioRxiv.

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Bertrand Z. Yeung, Madeleine K. D. Scott, B. Pulendran, 2020, Nature Medicine.

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Bertrand Z. Yeung, Madeleine K. D. Scott, B. Pulendran, 2020, Nature Medicine.

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies

Feng Gao, Tongqing Zhou, Thomas B. Kepler, 2014, Cell.

4E10-Resistant Variants in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Individual with an Anti-Membrane-Proximal External Region-Neutralizing Antibody Response

G. Shaw, F. Bibollet-Ruche, L. Morris, 2007, Journal of Virology.

Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.

W. Blattner, J. Sninsky, G. Shaw, 1990, The Journal of infectious diseases.

Characterization of CFTR expression and chloride channel activity in human endothelia.

G. Shaw, B. V. Van Tine, L. Schwiebert, 1998, American journal of physiology. Cell physiology.

erratum: Antibody neutralization and escape by HIV-1

M. Nowak, J. Kappes, N. Komarova, 2003, Nature.

The human T-cell leukemia virus family, adult T cell leukemia, and AIDS.

M. Reitz, G. Shaw, R. Gallo, 1985, Haematology and blood transfusion.

Foci of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii)

J. Brookfield, P. Sharp, G. Shaw, 2003, Journal of Virology.

Amplification of a Complete Simian Immunodeficiency Virus Genome from Fecal RNA of a Wild Chimpanzee

P. Sharp, G. Shaw, A. Pusey, 2003, Journal of Virology.

Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation.

D. Ho, D. Robertson, L. Kostrikis, 2001, AIDS research and human retroviruses.

A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys.

M. Soares, D. Robertson, G. Shaw, 1997, Virology.

Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild

P. Sharp, R. Desrosiers, J. Rogers, 1994, Journal of virology.

Virus Reservoir Represent a Simian Immunodeficiency Eastern Chimpanzees, but Not Bonobos,

V. Reynolds, G. Shaw, B. Hahn, 2012 .

High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees

G. Learn, P. Sharp, G. Shaw, 2011, Journal of Virology.

Generation of Infectious Molecular Clones of Simian Immunodeficiency Virus from Fecal Consensus Sequences of Wild Chimpanzees

Z. Weng, P. Sharp, G. Shaw, 2007, Journal of Virology.

Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2).

P. Sharp, G. Shaw, B. Hahn, 2004, AIDS research and human retroviruses.

Origin of AIDS: Contaminated polio vaccine theory refuted

P. Sharp, A. Rambaut, G. Shaw, 2004, Nature.

Noninvasive detection of Simian immunodeficiency virus infection in a wild-living L'Hoest's monkey (Cercopithecus Ihoesti).

N. Gross-Camp, P. Sharp, G. Shaw, 2003, AIDS research and human retroviruses.

Single genome amplification and direct amplicon sequencing of Plasmodium spp. DNA from ape fecal specimens.

J. Rayner, P. Sharp, G. Shaw, 2010, Protocol exchange.

Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians.

W. Blattner, M. Taylor, G. Shaw, 1992, The Journal of infectious diseases.

Lack of viral latency of human T-cell lymphotropic virus type I.

W. Blattner, M. Taylor, G. Shaw, 1991, The New England journal of medicine.

A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.

P. Sharp, G. Shaw, P. Fultz, 1993, Virology.

Parasite to Prevention: Advances in the understanding of malaria

Rayner, G. Learn, A. Cowman, 2010 .

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.

David C Montefiori, Georgia D Tomaras, Avishek Nandi, 2010, Virology.

Potent Anti-Viral Activity of a Trispecific HIV Antibody in SHIV-Infected Monkeys

J. Mascola, R. Koup, J. Lifson, 2021, SSRN Electronic Journal.

Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells

Michael D. McLean, D. Burton, G. Shaw, 2021, Journal of virology.

New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure

B. Haynes, J. Lifson, G. Shaw, 2021, Journal of Virology.

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection

B. Pulendran, G. Shaw, A. Ward, 2021, PLoS Pathogens.

Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.

B. Haynes, J. Weiner, D. Montefiori, 2020, Cell reports.

Oral clade C SHIV challenge models to study pediatric HIV-1 infection by breastmilk transmission

Alan D. Curtis, M. Hudgens, J. Lifson, 2019, bioRxiv.

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

M. Hudgens, J. Mascola, D. Montefiori, 2011, Science Translational Medicine.

SHIV.CH505-infected infant and adult rhesus macaques exhibit similar HIV Env-specific antibody kinetics, despite distinct T-follicular helper (Tfh) and germinal center B cell landscapes

M. Hudgens, G. Shaw, K. Bar, 2019, bioRxiv.

Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection.

G. Learn, G. Shaw, S. Ray, 2018, Cell host & microbe.

Researchenhancement of HIV infection is donor-dependent and correlates with the levels of SEVI

W. Greene, G. Shaw, F. Kirchhoff, 2010 .

Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.

G. Shaw, S. Broder, M. Essex, 1984, Advances in internal medicine.

Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site

G. Shaw, J. Decker, E. Hunter, 2004, Journal of Virology.

Sensitivity of Human Immunodeficiency Virus Type 1 to Fusion Inhibitors Targeted to the gp41 First Heptad Repeat Involves Distinct Regions of gp41 and Is Consistently Modulated by gp120 Interactions with the Coreceptor

G. Shaw, W. O'brien, J. Decker, 2001, Journal of Virology.

Transmission of human T‐lymphotropic virus type I by blood components from a donor lacking anti‐p24: a case report

G. Shaw, H. Lee, J. Mosley, 1992, Transfusion.

Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.

W. Blattner, J. Sninsky, G. Shaw, 1991, The Journal of infectious diseases.

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates

J. Mullins, G. Shaw, C. Bollard, 2023, Frontiers in Immunology.

Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site

Tongqing Zhou, Gary J. Nabel, Peter D. Kwong, 2009, PLoS pathogens.

The Family of Human T-Cell Leukemia Viruses and Their Role in the Cause of T-Cell Leukemia and AIDS

M. Reitz, G. Shaw, B. Hahn, 1985 .

A Plea for Justice for Jailed Medical Workers

A. Trkola, R. Schooley, M. Lederman, 2006, Science.

B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4

J. Mascola, R. Wyatt, G. Shaw, 2008, PLoS pathogens.

Unique Mutational Patterns in the Envelope α2 Amphipathic Helix and Acquisition of Length in gp120 Hypervariable Domains Are Associated with Resistance to Autologous Neutralization of Subtype C Human Immunodeficiency Virus Type 1

S. Gnanakaran, Bette T. Korber, Cynthia A. Derdeyn, 2007, Journal of Virology.

Primary HIV-1 infection.

S. J. Clark, D. Ho, J. Levy, 1991, The New England journal of medicine.

Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection

B. Korber, P. Hraber, B. Haynes, 2018, Nature Communications.

Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo.

B T Foley, H Hui, B. Korber, 2001, AIDS research and human retroviruses.

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis

G. Learn, G. Shaw, B. Hahn, 2013, Retrovirology.

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis

G. Learn, F. Gao, G. Shaw, 2013, Retrovirology.

Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.

G. Shaw, F. Stricher, P. Kwong, 2008, Journal of molecular biology.

Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques

T. Kepler, A. Bartesaghi, M. Borgnia, 2020, bioRxiv.

Spontaneous lymphocyte proliferation in HTLV-II infection

W. Blattner, G. Shaw, J. Reuben, 1991, The Lancet.

Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors.

I. Williams, G. Shaw, P. Borrow, 2012, Blood.

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection

H. Liao, Laura L. Sutherland, B. Haynes, 2016, EBioMedicine.

Zoonotic origin of the human malaria parasite Plasmodium malariae from African apes

P. Sharp, G. Shaw, N. Wolfe, 2022, Nature Communications.

Edinburgh Research Explorer Simian immunodeficiency virus infection in free-ranging sooty Mangabeys (Cercocebus atys atys) from the Tai Forest, Cote

J. Brookfield, P. Sharp, G. Shaw, 2005 .

Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group.

G. Shaw, M. Busch, J. Mosley, 1990, Annals of internal medicine.

Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.

M. Gonda, G. Shaw, B. Hahn, 1984, Princess Takamatsu symposia.

Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques

G. Shaw, M. Davenport, I. Georgiev, 2022, bioRxiv.

Generation of Infectious Molecular Clones of Simian Immunodeficiency Virus from Fecal Consensus Sequences of Wild Chimpanzees

Z. Weng, P. Sharp, G. Shaw, 2007, Journal of Virology.

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers

J. Mellors, G. Shaw, R. Ribeiro, 2016, PLoS pathogens.

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques

B. Pulendran, D. Montefiori, G. Shaw, 2023, Nature communications.

Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaques

R. Siliciano, G. Shaw, G. Silvestri, 2023, bioRxiv.

A SSESSING THE EFFECT OF ANTIBODY RESPONSES ON VIRAL REBOUND DYNAMICS IN POSTNATALLY SHIV-INFECTED INFANT R HESUS MACAQUES

G. Shaw, G. Silvestri, G. Fouda, 2023 .

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization

J. Sodroski, F. Gao, P. Sharp, 1996, Journal of virology.

J. Brookfield, P. Sharp, G. Shaw, 2006, Journal of Virology.

Edinburgh Research Explorer Simian immunodeficiency virus infection in free-ranging sooty Mangabeys (Cercocebus atys atys) from the Tai Forest, Cote

J. Brookfield, P. Sharp, G. Shaw, 2018 .

HTLV-III and the etiology of AIDS.

G. Shaw, B. Hahn, M. Robert-Guroff, 1986, Progress in allergy.

Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users

G. Learn, B. Haynes, C. Morgan, 2010, Journal of Virology.

Human Monocyte Cytotoxicity to Tumor Cells

G. Shaw, A. Lobuglio, P. C. Levy, 1978, The Journal of Immunology.